M N 25 (Ropinirole 0.25 mg)

Pill imprint M N 25 has been identified as Ropinirole hydrochloride 0.25 mg.

Ropinirole is used in the treatment of parkinson's disease; restless legs syndrome; periodic limb movement disorder; tardive dyskinesia and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Ropinirole 0.25 mg is not a controlled substance under the Controlled Substance Act (CSA).

Ropinirole hydrochloride

Imprint:

M N 25

Strength:

0.25 mg

Color:

White

Size:

6.00 mm

Shape:

Round

Availability:

Prescription only

Drug Class:

Dopaminergic antiparkinsonism agents

Pregnancy Category:

C - Risk cannot be ruled out

CSA Schedule:

Not a controlled drug

Manufacturer:

Mylan Pharmaceuticals Inc.

National Drug Code (NDC):

00378-5525

Inactive Ingredients:

lactose anhydrous
silicon dioxide
croscarmellose sodium
magnesium stearate
microcrystalline cellulose

Other Manufacturers / Repackagers:

NDC Code	Manufacturer / Repackager
16590-0849	Stat RX USA LLC (repackager)

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.